BUCHI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.166
EU - Europa 1.118
AS - Asia 191
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
SA - Sud America 2
Totale 2.490
Nazione #
US - Stati Uniti d'America 1.161
IT - Italia 648
RU - Federazione Russa 197
PL - Polonia 74
HK - Hong Kong 61
SG - Singapore 54
IE - Irlanda 50
SE - Svezia 49
CN - Cina 37
CH - Svizzera 26
GB - Regno Unito 14
FI - Finlandia 13
VN - Vietnam 12
DE - Germania 11
FR - Francia 11
IN - India 9
UA - Ucraina 9
AU - Australia 6
ID - Indonesia 6
TR - Turchia 6
CA - Canada 5
AT - Austria 4
ES - Italia 4
EU - Europa 4
NL - Olanda 3
AZ - Azerbaigian 2
BE - Belgio 2
BR - Brasile 2
CI - Costa d'Avorio 2
PT - Portogallo 2
AL - Albania 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 2.490
Città #
Santa Clara 285
Fairfield 150
Ashburn 74
Warsaw 72
Woodbridge 67
Cambridge 64
Seattle 61
Chandler 58
Hong Kong 53
Dublin 50
Houston 45
Rome 40
Wilmington 39
Singapore 36
Milan 32
Florence 31
Ann Arbor 29
Altamura 24
Bern 22
Lawrence 22
Beijing 17
Genova 17
Princeton 16
Bologna 15
Naples 14
Jacksonville 13
Dong Ket 12
Medford 12
Shanghai 10
Mumbai 9
Boardman 7
San Diego 7
Venice 7
Cagliari 6
Izmir 6
Jakarta 6
Melbourne 6
Modena 6
Seravezza 6
Kent 5
Padova 5
Turin 5
Boston 4
Buffalo 4
Canzo 4
Ferrara 4
Genoa 4
Gradara 4
Los Angeles 4
Moscow 4
Trieste 4
Bari 3
Campodarsego 3
Campogalliano 3
Cusano Milanino 3
Mira 3
Nuremberg 3
Parma 3
Toronto 3
Udine 3
Vienna 3
Vigonza 3
Yubileyny 3
Abidjan 2
Alghero 2
Arezzo 2
Arlington 2
Bremen 2
Brussels 2
Caltanissetta 2
Carpi 2
Casatenovo 2
Cecina 2
Cologno Monzese 2
Como 2
Corridonia 2
Desio 2
Duncan 2
Eupilio 2
Farindola 2
Foligno 2
Forlì 2
Gorizia 2
Gubbio 2
Jerago Con Orago 2
Lleida 2
London 2
L’Aquila 2
Macerata 2
Marseille 2
Massafra 2
Melendugno 2
Monopoli 2
Montréal 2
Motta Visconti 2
Norwalk 2
Palermo 2
Paris 2
Perugia 2
Peschiera Borromeo 2
Totale 1.607
Nome #
Effetto dei farmaci ipometilanti, azacitidina e decitabina, sul proteoma e sul rimodellamento cromatinico di cellule di Leucemia Mieloide Acuta AML1/ETO positive 834
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. 159
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. 155
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. 155
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 142
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 139
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. 137
Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance. 136
Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. 133
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes 133
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia 133
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. 127
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. 127
Totale 2.510
Categoria #
all - tutte 5.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 0 0 26 23 24 10
2020/2021279 15 12 2 12 9 62 30 31 31 38 10 27
2021/2022171 11 16 14 3 13 11 4 9 9 10 16 55
2022/2023394 30 59 27 27 23 64 39 18 37 19 19 32
2023/2024216 23 17 26 23 15 11 15 39 11 10 15 11
2024/2025703 39 87 52 116 206 144 8 38 13 0 0 0
Totale 2.510